Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$636M |
| 2 |
UnitedHealth
UNH
|
+$635M |
| 3 |
Estee Lauder
EL
|
+$632M |
| 4 |
AbbVie
ABBV
|
+$466M |
| 5 |
PayPal
PYPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
O'Reilly Automotive
ORLY
|
+$559M |
| 2 |
SHPG
Shire pic
SHPG
|
+$464M |
| 3 |
Amazon
AMZN
|
+$458M |
| 4 |
Ulta Beauty
ULTA
|
+$439M |
| 5 |
Alibaba
BABA
|
+$397M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.96% |
| 2 | Healthcare | 15.31% |
| 3 | Consumer Discretionary | 14.83% |
| 4 | Communication Services | 12.99% |
| 5 | Financials | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Dominion Energy
D
$62.5B
| $58.4M | 0.06% |
759,077
-41,183
| -5% | -$3.2M |
|
252
Pembina Pipeline
PBA
$29.3B
| $57.7M | 0.06% |
1,644,993
+373,984
| +29% | +$12.5M |
|
|
AXE
253
DELISTED
Anixter International Inc
AXE
| $57.4M | 0.06% |
674,785
+79,274
| +13% | +$6.09M |
|
|
BIVV
254
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $56.4M | 0.06% |
+988,614
| New | +$57.9M |
|
255
US Foods
USFD
$21.8B
| $56.4M | 0.06% |
2,111,897
+459,783
| +28% | +$12.6M |
|
256
Kinder Morgan
KMI
$71.3B
| $55.6M | 0.06% |
2,899,402
-131,804
| -4% | -$2.57M |
|
257
GE Aerospace
GE
$372B
| $55.3M | 0.06% |
477,234
-79,855
| -14% | -$9.65M |
|
|
SAGE
258
DELISTED
Sage Therapeutics
SAGE
| $54.4M | 0.06% |
873,750
-215,778
| -20% | -$16.9M |
|
|
TXNM
259
TXNM Energy Inc
TXNM
$6.47B
| $53.8M | 0.06% |
1,335,706
| – | – |
|
260
Southern Company
SO
$110B
| $53.6M | 0.05% |
1,090,400
+121,157
| +13% | +$5.87M |
|
261
Marvell Technology
MRVL
$166B
| $52.3M | 0.05% |
2,919,037
+699,719
| +32% | +$11.6M |
|
262
Integra LifeSciences
IART
$1.56B
| $52.2M | 0.05% |
1,034,702
+336,930
| +48% | +$17.3M |
|
|
FCE.A
263
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $52.2M | 0.05% |
2,046,306
+1,598
| +0.1% | +$39.1K |
|
264
Universal Health Services
UHS
$9.74B
| $52.1M | 0.05% |
469,483
-2,012
| -0.4% | -$227K |
|
265
Sarepta Therapeutics
SRPT
$1.71B
| $51.9M | 0.05% |
1,143,853
+582,894
| +104% | +$23.3M |
|
|
XENT
266
DELISTED
Intersect ENT, Inc
XENT
| $51.8M | 0.05% |
1,663,882
-616,916
| -27% | -$18.3M |
|
|
NSA
267
DELISTED
National Storage Affiliates Trust
NSA
| $51.2M | 0.05% |
2,114,041
+34,400
| +2% | +$781K |
|
|
AGN.PRA
268
DELISTED
Allergan plc
AGN.PRA
| $51M | 0.05% |
69,082
-3,641
| -5% | -$3.02M |
|
|
DBVT
269
DBV Technologies
DBVT
$817M
| $50.6M | 0.05% |
119,293
+19,086
| +19% | +$8.18M |
|
270
Henry Schein
HSIC
$9.78B
| $50.5M | 0.05% |
785,352
-617,191
| -44% | -$42.1M |
|
271
Fortinet
FTNT
$113B
| $50.3M | 0.05% |
7,019,185
-1,790,940
| -20% | -$13.6M |
|
|
GWPH
272
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $50M | 0.05% |
492,480
+1,759
| +0.4% | +$188K |
|
273
Intuit
INTU
$83.9B
| $49.8M | 0.05% |
350,676
-175,646
| -33% | -$24.2M |
|
274
Pebblebrook Hotel Trust
PEB
$2.17B
| $49.6M | 0.05% |
1,373,209
-14,814
| -1% | -$492K |
|
|
CLVS
275
DELISTED
Clovis Oncology, Inc.
CLVS
| $49.5M | 0.05% |
600,169
-585,008
| -49% | -$46.4M |
|
Similar funds
Jennison Associates's Q3 2017 Portfolio in Review
As of Q3 2017, Jennison Associates held 727 positions worth $97.6B, up 3.6% from $94.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jennison Associates withdrew a net $3.38B in Q3 2017, closing 79 positions and reducing 330 holdings. Its most notable exit was O'Reilly Automotive, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in Estee Lauder worth $664M.
- Jennison Associates's largest Q3 2017 buy was Estee Lauder: 6,161,274 shares worth $664M.
- Jennison Associates added most to Alexion Pharmaceuticals in Q3 2017, an estimated $636M increase.
- Jennison Associates's biggest Q3 2017 reduction was Shire pic, cutting an estimated $464M.
- Jennison Associates fully exited O'Reilly Automotive in Q3 2017, selling an estimated $559M.
- Jennison Associates's ten largest holdings make up 28% of its $97.6B portfolio in Q3 2017.
- Jennison Associates opened 90 new positions and closed 79 in Q3 2017.
- Jennison Associates's portfolio value rose 3.6% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2017, filed 3 Nov 2017.